Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.05 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |